Aberdeen Wealth Management’s Boston Scientific BSX Stock Holding History

Aberdeen Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$484K	Hold	7,720	–	–	0.22%	92
2025 Q4	$736K	Hold	7,720	–	–	0.34%	64
2025 Q3	$754K	Hold	7,720	–	–	0.47%	62
2025 Q2	$829K	Hold	7,720	–	–	0.55%	56
2025 Q1	$779K	Hold	7,720	–	–	0.54%	52
2024 Q4	$690K	Sell	7,720 -250	-3%	-$22K	0.47%	62
2024 Q3	$668K	Hold	7,970	–	–	0.44%	68
2024 Q2	$614K	Hold	7,970	–	–	0.42%	69
2024 Q1	$546K	Hold	7,970	–	–	0.32%	84
2023 Q4	$461K	Hold	7,970	–	–	0.33%	88
2023 Q3	$421K	Hold	7,970	–	–	0.32%	90
2023 Q2	$431K	Hold	7,970	–	–	0.31%	95
2023 Q1	$399K	Hold	7,970	–	–	0.3%	96
2022 Q4	$369K	Hold	7,970	–	–	0.28%	103
2022 Q3	$309K	Hold	7,970	–	–	0.27%	102
2022 Q2	$297K	Hold	7,970	–	–	0.24%	111
2022 Q1	$353K	Hold	7,970	–	–	0.24%	109
2021 Q4	$339K	Hold	7,970	–	–	0.22%	108
2021 Q3	$346K	Hold	7,970	–	–	0.33%	99
2021 Q2	$341K	Hold	7,970	–	–	0.31%	101
2021 Q1	$308K	Sell	7,970 -451	-5%	-$17.1K	0.24%	116
2020 Q4	$303K	Buy	8,421 +451	+6%	+$16.3K	0.23%	110
2020 Q3	$305K	Sell	7,970 -637	-7%	-$24.5K	0.29%	99
2020 Q2	$302K	Buy	8,607 +230	+3%	+$8.28K	0.32%	95
2020 Q1	$273K	Hold	8,377	–	–	0.33%	92
2019 Q4	$379K	Buy	+8,377	New	+$351K	0.28%	91

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aberdeen Wealth Management's BSX Position: Q1 2026 in Review

Aberdeen Wealth Management held its Boston Scientific (BSX) position steady in Q1 2026 at 7,720 shares worth $484K. The position accounts for 0.22% of the portfolio, ranked #92.

Aberdeen Wealth Management first reported a position in BSX in Q4 2019 and has held it in 26 quarters since. The position peaked at $829K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Aberdeen Wealth Management held 7,720 shares of Boston Scientific worth $484K as of Q1 2026.
Aberdeen Wealth Management left its Boston Scientific share count unchanged in Q1 2026.
Boston Scientific made up 0.22% of Aberdeen Wealth Management's portfolio in Q1 2026, its #92 holding.
Aberdeen Wealth Management first reported a position in Boston Scientific in Q4 2019 and has held it in 26 quarters since.
Aberdeen Wealth Management's Boston Scientific position peaked at $829K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Aberdeen Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.